Skip to content

Katherine Stueland, Chief Executive Officer at GeneDx, sold WGS on Jun 16, 2026

Data as of Oct 16

▼ SELL$128K2,140 shares at $59.75Katherine Stueland Chief Executive OfficerWGS GeneDx Holdings Corp.
Watch WGS
Traded
Jun 16, 2026
Disclosed
Jun 18, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Katherine Stueland, Chief Executive Officer at GeneDx, sold WGS on Jun 16, 2026TRADEDDISCLOSED
WGSSimilar stocks (XLV — its sector index fund), rebased to WGS's price on the disclosure day
WGS since disclosure
+7.8%
after the sale
Similar stocks (XLV) since disclosure
+18.3%
XLV — its sector index fund

Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKatherine Stueland Chief Executive OfficerWGS GeneDx Holdings Corp.$361Kdisclosed Jun 18 · filed 2 days after the trade
  2. ▼ SELLKatherine Stueland Chief Executive OfficerWGS GeneDx Holdings Corp.$149Kdisclosed Jun 18 · filed 2 days after the trade

See every trade on WGS →